Advertisement · 728 × 90

Posts by JAMA Dermatology

AI-powered application interface showing skin conditions: Case details section lists symptoms like joint pain, size increase, itching for a male, 50-59 y. Matching conditions carousel shows Cyst, Melanoma, Sebaceouse carcinoma. Info page lists skin cancer symptoms, treatments.

AI-powered application interface showing skin conditions: Case details section lists symptoms like joint pain, size increase, itching for a male, 50-59 y. Matching conditions carousel shows Cyst, Melanoma, Sebaceouse carcinoma. Info page lists skin cancer symptoms, treatments.

Access to an #AI-powered tool improved layperson accuracy in naming #SkinConcerns compared with traditional search, but did not increase accuracy of next-step decisions.

ja.ma/3QbO29k

8 hours ago 0 0 0 0
A medical article titled "Definition of Severity and Relapse for Vitiligo: An International Consensus Statement" by JAMA Dermatology. The article discusses the need for an international consensus on vitiligo severity, study methods, and criteria.

A medical article titled "Definition of Severity and Relapse for Vitiligo: An International Consensus Statement" by JAMA Dermatology. The article discusses the need for an international consensus on vitiligo severity, study methods, and criteria.

New international consensus classifies #Vitiligo severity with expanded clinical and psychosocial criteria and standardizes relapse as renewed depigmentation of once repigmented skin. ja.ma/4sojxdH

13 hours ago 0 0 0 0
Figure 1: Diagrams of Longitudinal Study Design in Denmark and England. It shows two diagrams comparing Denmark and England cohorts, starting from birth, various assessment windows (inclusion, covariate, exposure, exclusion), and follow-up periods. The Denmark cohort(1986-2000) follows until grade 9 by 2018. The England cohort(1991-1992) follows up to national test by June 2009.

Figure 1: Diagrams of Longitudinal Study Design in Denmark and England. It shows two diagrams comparing Denmark and England cohorts, starting from birth, various assessment windows (inclusion, covariate, exposure, exclusion), and follow-up periods. The Denmark cohort(1986-2000) follows until grade 9 by 2018. The England cohort(1991-1992) follows up to national test by June 2009.

Among more than 780 000 children in Denmark and England, #AtopicDermatitis was not linked to poorer academic performance on national exams regardless of disease phenotype or socioeconomic background. ja.ma/4sWyepu

2 days ago 2 0 0 0
Post image

#Sunscreen is essential for preventing sun damage, premature aging, & #SkinCancer.

This JAMA Dermatology Patient Page provides a concise, dermatologist-approved guide to help you make the most of your sunscreen.

ja.ma/4mgfsXJ

3 days ago 1 1 0 0
Post image

A man in his 70s was admitted with a symptomatic impending rupture of a thoracic aortic aneurysm, followed by reticulate erythematous to violaceous macules that appeared on the dorsal & plantar surfaces of both feet.

Take the Clinical Challenge: ja.ma/4tBSgVY

5 days ago 1 1 0 0

A man in his 70s was admitted with a symptomatic impending rupture of a thoracic aortic aneurysm, followed by reticulate erythematous to violaceous macules that appeared on the dorsal & plantar surfaces of both feet. Take the Clinical Challenge: ja.ma/4tBfQT7

5 days ago 0 0 0 0
JAMA Dermatology article, "Racially Minoritized Families’ Perspectives on Barriers and Facilitators to Pediatric Dermatology Care" by Elizabeth Garcia-Creighton, Molly Thapar, and Nicholas A. Felan. Published April 8, 2026.

JAMA Dermatology article, "Racially Minoritized Families’ Perspectives on Barriers and Facilitators to Pediatric Dermatology Care" by Elizabeth Garcia-Creighton, Molly Thapar, and Nicholas A. Felan. Published April 8, 2026.

#PediatricDermatology care for racially minoritized families was impeded by factors such as unfamiliarity with dermatology, language barriers, long wait times, and lack of representation, but facilitated by parental advocacy and clinician communication.

ja.ma/4czIRZm

6 days ago 0 0 0 0
Post image

Among more than 780 000 children in Denmark and England, #AtopicDermatitis was not linked to poorer academic performance on national exams regardless of disease phenotype or socioeconomic background. ja.ma/4sWyepu

1 week ago 2 1 0 0
Figure 4: Box plots of accuracy, balanced accuracy, sensitivity, and specificity for AI, dermatologists, and their combination, and summary ROC curves for diagnostic methods, with AI and dermatologists sensitivity vs 1-specificity.

Figure 4: Box plots of accuracy, balanced accuracy, sensitivity, and specificity for AI, dermatologists, and their combination, and summary ROC curves for diagnostic methods, with AI and dermatologists sensitivity vs 1-specificity.

#AI-assisted dermoscopy matched or exceeded dermatologist performance for #Melanoma detection in prospective studies, but broader clinical validation is needed for routine use. ja.ma/4c4dwy5

1 week ago 0 0 0 0
A medical article titled "Definition of Severity and Relapse for Vitiligo: An International Consensus Statement" by JAMA Dermatology. The article discusses the need for an international consensus on vitiligo severity, study methods, and criteria.

A medical article titled "Definition of Severity and Relapse for Vitiligo: An International Consensus Statement" by JAMA Dermatology. The article discusses the need for an international consensus on vitiligo severity, study methods, and criteria.

New international consensus classifies #Vitiligo severity with expanded clinical and psychosocial criteria and standardizes relapse as renewed depigmentation of once repigmented skin. ja.ma/3PPKtWg

1 week ago 0 0 0 0
Advertisement
Figure 1. Clinical Image of Both Legs. Bilateral lower legs show well-defined atrophic yellow-brown plaques with mild scale.

Figure 1. Clinical Image of Both Legs. Bilateral lower legs show well-defined atrophic yellow-brown plaques with mild scale.

This case report describes well-circumscribed, yellow-brown atrophic plaques on the legs that were rimmed by erythema and scale.

ja.ma/41enuGJ

1 week ago 1 2 0 0
JAMA Dermatology Research Letter: "Sleep Disturbance as a Mediator Between Itch and Quality of Life" by Elise Edwards text@1, Ladonya Jackson-Cowan, MD, PhD text@1, Nicole Khalil, BS text@1, et al. Published online January 28, 2026.

JAMA Dermatology Research Letter: "Sleep Disturbance as a Mediator Between Itch and Quality of Life" by Elise Edwards text@1, Ladonya Jackson-Cowan, MD, PhD text@1, Nicole Khalil, BS text@1, et al. Published online January 28, 2026.

Among patients with chronic pruritus, sleep problems contributed more to daily functional impairment and were most significant in pruriceptive itch. ja.ma/4v6u3Jj

1 week ago 0 0 0 0
Bar chart shows HPV genotype frequency across tissue sites. The X-axis lists 65 HPV genotypes: A@number, B@number, and G@number. Y-axis shows the frequency. 'Most frequently detected HPV genotype' highlighted in blue bars.

Bar chart shows HPV genotype frequency across tissue sites. The X-axis lists 65 HPV genotypes: A@number, B@number, and G@number. Y-axis shows the frequency. 'Most frequently detected HPV genotype' highlighted in blue bars.

#CutaneousSquamousCellCarcinoma in Asian organ transplant recipients and immunocompetent patients featured distinct distributions of 65 #HPV genotypes, with B-HPV showing the greatest site overlap.

ja.ma/4sUwf5a

1 week ago 0 0 0 0
Close-up of two hands, palms up, showing signs of aging with wrinkled skin. Knuckles on each finger appear enlarged. The hands are placed on a plain surface, capturing skin texture and nail details.

Close-up of two hands, palms up, showing signs of aging with wrinkled skin. Knuckles on each finger appear enlarged. The hands are placed on a plain surface, capturing skin texture and nail details.

📄 This case report describes large areas of erythema on the face, chest, and back with relatively clear boundaries and swollen hands with scattered skin-colored papules and nodules.

ja.ma/41tiG0t

1 week ago 1 2 0 0
Clinical Risk Scoring System algorithm: Clinical symptoms(Hoarseness +2 points, Dysphagia +4 points), Disease severity for male(High PDAI@18 +2 points) and female patients(High PDAI@18 +1 point). Risk interpretation: Low, Intermediate and High risk.

Clinical Risk Scoring System algorithm: Clinical symptoms(Hoarseness +2 points, Dysphagia +4 points), Disease severity for male(High PDAI@18 +2 points) and female patients(High PDAI@18 +1 point). Risk interpretation: Low, Intermediate and High risk.

A clinical prediction model for #PemphigusVulgaris using hoarseness, dysphagia, and disease severity accurately predicted deep laryngeal involvement and may help guide laryngoscopy decisions.

ja.ma/418ZSU2

1 week ago 0 0 0 0
An X-ray shows bones of a left hand. White arrows point to areas on three fingers. A yellow arrow points to the thumb area. "Figure 2. Left Hand Radiography" and a scale marked "80mm" are visible.

An X-ray shows bones of a left hand. White arrows point to areas on three fingers. A yellow arrow points to the thumb area. "Figure 2. Left Hand Radiography" and a scale marked "80mm" are visible.

This case report describes a man in his 30s who was referred for the evaluation of a 3-month destructive process affecting the nail matrix and nail plate of the left thumbnail. ja.ma/48nbaYx

1 week ago 0 0 0 0
Figure 1. Cumulative incidence curve showing 10-year standardized cumulative incidences and absolute risk differences for skin cancer. The graph plots the risk of skin cancer (%) over time since CLL diagnosis (years) for patients with CLL and controls.

Figure 1. Cumulative incidence curve showing 10-year standardized cumulative incidences and absolute risk differences for skin cancer. The graph plots the risk of skin cancer (%) over time since CLL diagnosis (years) for patients with CLL and controls.

Individuals with #ChronicLymphocyticLeukemia faced increased risk of skin cancer-specific metastasis and death compared with controls especially #BasalCellCarcinoma and #SquamousCellCarcinoma, though the absolute risk remained low.

ja.ma/47yZ8ev

2 weeks ago 1 1 0 0
Advertisement
Survival analysis of disease flare: Graph shows percentage of patients without a flare over time (in months) after starting medications. Lines represent MTX, MMF, and CT treatments. Number of patients at risk for each treatment is also listed.

Survival analysis of disease flare: Graph shows percentage of patients without a flare over time (in months) after starting medications. Lines represent MTX, MMF, and CT treatments. Number of patients at risk for each treatment is also listed.

Among patients with juvenile localized scleroderma, mycophenolate mofetil and methotrexate showed comparable efficacy, but mycophenolate mofetil had improved tolerability. ja.ma/4v2f5np

2 weeks ago 0 0 0 0
COSMIN Ratings and GRADE Certainty of Evidence of Other Measurement Properties for HS-Specific PROMs. The table lists various PROMs(HISQOL-17, HISQOL-23, PtGA-HS, HODS) and rates them based on structural validity, internal consistency, responsiveness, reliability and construct validity.

COSMIN Ratings and GRADE Certainty of Evidence of Other Measurement Properties for HS-Specific PROMs. The table lists various PROMs(HISQOL-17, HISQOL-23, PtGA-HS, HODS) and rates them based on structural validity, internal consistency, responsiveness, reliability and construct validity.

Seven #HidradenitisSuppurativa–specific patient-reported outcome measures met COSMIN criteria for sufficient validity, with HiSQOL-17 rated strongest for reliability and responsiveness.

ja.ma/3Nxs9QU

2 weeks ago 0 0 0 0
The figure shows clinical and histopathologic images of a patient treated with Baricitinib. A and B are clinical images of the dorsal hand at presentation and after 16-wk treatment, respectively. C and D are anhidrotic and normohidrotic areas.

The figure shows clinical and histopathologic images of a patient treated with Baricitinib. A and B are clinical images of the dorsal hand at presentation and after 16-wk treatment, respectively. C and D are anhidrotic and normohidrotic areas.

This case report describes 2 otherwise healthy patients who presented with acquired idiopathic generalized anhidrosis and were treated with baricitinib. ja.ma/3NmdBne

2 weeks ago 1 1 0 0
A clinical image shows a left upper extremity with blisters, alongside a hematoxylin-eosin stain image at ×200 magnification. Text: 'Clinical image of left upper extremity,' 'Hematoxylin-eosin stain (original magnification ×200)'

A clinical image shows a left upper extremity with blisters, alongside a hematoxylin-eosin stain image at ×200 magnification. Text: 'Clinical image of left upper extremity,' 'Hematoxylin-eosin stain (original magnification ×200)'

A neonate presents with a 1-day history of 15 discrete 2- to 10-mm tense and flaccid yellow vesicles and bullae on the chest, arms, and legs as well as subtle flexural erythema but is otherwise well appearing.

What is your diagnosis? ja.ma/478IulK

2 weeks ago 0 0 0 0
JAMA Dermatology "Research Letter: Diagnosis, Workup, and Treatment of Idiopathic Granulomatous Mastitis" by Isabel C. Yoon@1, Roxana Shirazi@2, Varshini Babu@1, et al. Published Online March 25, 2026. doi: 10.1001/jamadermatol.2026.0176

JAMA Dermatology "Research Letter: Diagnosis, Workup, and Treatment of Idiopathic Granulomatous Mastitis" by Isabel C. Yoon@1, Roxana Shirazi@2, Varshini Babu@1, et al. Published Online March 25, 2026. doi: 10.1001/jamadermatol.2026.0176

Idiopathic granulomatous mastitis was diagnosed after exclusion of infectious and autoimmune causes, with most patients managed by surgical oncology using antibiotics, steroids, and aspiration; long-term doxycycline reduced recurrence.

ja.ma/4swgNf4

2 weeks ago 1 1 0 0
Green promotional graphic for JAMA Dermatology's 'Meet Our Editors' event on Sunday, March 29. The event features Rob Micheletti (Images Editor) from 10-11 AM, Cristy Garza-Mayers (Editorial Fellow) from 11 AM-12 PM, and Kanade Shinkai (Editor) from 12-2 PM. Visit them in booth #3248.

Green promotional graphic for JAMA Dermatology's 'Meet Our Editors' event on Sunday, March 29. The event features Rob Micheletti (Images Editor) from 10-11 AM, Cristy Garza-Mayers (Editorial Fellow) from 11 AM-12 PM, and Kanade Shinkai (Editor) from 12-2 PM. Visit them in booth #3248.

👋🎉 Stop by booth 3248 today at #AAD2026 to meet the JAMA Dermatology editors:

• Rob Micheletti, MD
• Cristy Garza-Mayers, MD
• Kanade Shinkai, MD, PhD

2 weeks ago 1 0 0 0
Two graphs show cumulative acne incidence over 5 years. Graph A shows transmasculine individuals, cisgender men, and cisgender women. Graph B shows transgender women, cisgender men, and cisgender women. The y-axis is "Cumulative acne incidence, %."

Two graphs show cumulative acne incidence over 5 years. Graph A shows transmasculine individuals, cisgender men, and cisgender women. Graph B shows transgender women, cisgender men, and cisgender women. The y-axis is "Cumulative acne incidence, %."

Moderate to severe #Acne incidence was greatest within the first year after testosterone for transmasculine individuals vs cisgender comparators.

ja.ma/4bXvv8Y

2 weeks ago 0 0 0 0
Medical article titled: 'A Woman With Pulmonary Arterial Hypertension, Hemangiomas, and Hyperpigmentation' featuring clinical photos of a hyperpigmented hand and a foot with a dome-shaped purple papule on a toe.

Medical article titled: 'A Woman With Pulmonary Arterial Hypertension, Hemangiomas, and Hyperpigmentation' featuring clinical photos of a hyperpigmented hand and a foot with a dome-shaped purple papule on a toe.

A woman in her 60s presents with a 3-year history of pulmonary arterial hypertension and 2-month history of worsening dyspnea and progressive abdominal distension.

📄 What is your diagnosis?

ja.ma/4lNndUN

2 weeks ago 0 0 0 0
Advertisement
JAMA Dermatology presents "Meet Our Editors" on Saturday, March 28. Editors present: Lauren Madigan, MD, Images Editor (11AM-12PM); John Barbieri, MD, Associate Editor (1-2PM); Howa Yeung, MD, MSc, Associate Editor (1-3PM); Aileen Chang & Courtney Schadt (4-5PM). Visit booth #3248.

JAMA Dermatology presents "Meet Our Editors" on Saturday, March 28. Editors present: Lauren Madigan, MD, Images Editor (11AM-12PM); John Barbieri, MD, Associate Editor (1-2PM); Howa Yeung, MD, MSc, Associate Editor (1-3PM); Aileen Chang & Courtney Schadt (4-5PM). Visit booth #3248.

👋🎉 Stop by booth 3248 today at #AAD2026 to meet the JAMA Dermatology editors:

• Lauren Madigan, MD
• John Barbieri, MD
• Howa Yeung, MD, MSc
• Aileen Chang, MD
• Courtney Schadt, MD

2 weeks ago 0 0 0 0
JAMA Dermatology presents a research letter titled "Risk of Acne in Patients With Atopic Dermatitis Starting a JAK Inhibitor vs Th2 Cytokine Inhibitor" by Maria C. Schneeweiss text@1, text@2, Richard Wyss, text@3, text@4, and Priyanka Anand.

JAMA Dermatology presents a research letter titled "Risk of Acne in Patients With Atopic Dermatitis Starting a JAK Inhibitor vs Th2 Cytokine Inhibitor" by Maria C. Schneeweiss text@1, text@2, Richard Wyss, text@3, text@4, and Priyanka Anand.

Among adults with #AtopicDermatitis, JAK inhibitor use was associated with more than double the 6-month risk of physician-recorded #Acne compared with Th2 cytokine inhibitor, with no difference seen for folliculitis or rosacea.

ja.ma/4d1MQ1O

2 weeks ago 0 0 0 0
Green background with 'AAD' logo in the top left and 'JN' logo in the top right corners. The text "Read papers from the JAMA Network™" is in the center, in a bold white font.

Green background with 'AAD' logo in the top left and 'JN' logo in the top right corners. The text "Read papers from the JAMA Network™" is in the center, in a bold white font.

📍 Attending #AAD2026?

📚 Identification of Risk Factors for Acral Melanoma in US Veterans from JAMA Dermatology
🔗 Free to read online during the meeting

ja.ma/3PqGnDQ

2 weeks ago 0 0 0 0
Presentation slide with "JAMA Network Editor Conference Presentation" in white text on gray. Below are colorful vertical stripes. Top right corner has "JN" in a circle.

Presentation slide with "JAMA Network Editor Conference Presentation" in white text on gray. Below are colorful vertical stripes. Top right corner has "JN" in a circle.

📅 Today | Fri, Mar 27 | 1–3 PM
✨ Kanade Shinkai, MD, PhD, Editor in Chief of JAMA Dermatology, presents The Best Articles of the Year
📍 Room: Mile High 4A

#AAD2026

2 weeks ago 0 0 0 0
Green background with white text: "Read papers from the JAMA Network™." The AAD logo is in the upper left and the JN logo in the upper right.

Green background with white text: "Read papers from the JAMA Network™." The AAD logo is in the upper left and the JN logo in the upper right.

At #AAD2026?

📚 Development of a Patient Decision Aid for Atopic Dermatitis Systemic Treatments in Adults from JAMA Dermatology

🔓 Free to read online during the meeting

ja.ma/4uVN9Bu

2 weeks ago 0 0 0 0